R

Avidity Biosciences
D

RNA

14.040
USD
0.75
(5.64%)
مغلق
حجم التداول
15,072
الربح لكل سهم
-4
العائد الربحي
-
P/E
-3
حجم السوق
217,830,123
المقالات
المزيد

العنوان: Atrium Therapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.